The tape was quiet but pointed. The S&P 500 ticked up 0.21% to 769.06, a modest gain that masks the real story: a handful of names, led by Moderna, absolutely ripped. When you see a 177% move in a single stock, something changed.
Market movers
|
S&P 500
769.06
+0.21%
|
Nasdaq 100
—
—
|
Dow Jones
—
—
|
Russell 2000
—
—
|
Volatility
—
—
|
| MRNX | Daily Target 2X Long MRNA ETF | 141.64 | +352.09% |
| MRNA | Moderna, Inc. | 174.38 | +176.97% |
| MRNY | YieldMax MRNA Option Income Strategy ETF | 42.00 | +169.23% |
| YJ | Yunji Inc. | 4.25 | +144.25% |
| TNON | Tenon Medical, Inc. | 11.41 | +109.36% |
| PFSA | Profusa, Inc. Common Stock | 13.57 | -50.62% |
| LGCL | Lucas GC Limited Ordinary Shares | 0.13 | -46.96% |
| IPST | IP Strategy Holdings, Inc. | 8.45 | -46.38% |
| KWM | K Wave Media Ltd. | 1.64 | -37.88% |
| WETO | Wetour Robotics Limited | 20.76 | -37.09% |
Moderna's surge dominated the tape—its 2X and options-strategy ETFs tracked right along, confirming genuine buying rather than retail meme action. The broader market shrug (S&P up a sliver) tells you this was sector-specific heat, not a broad risk-on rally. Losers in micro-cap land showed the usual suspects getting crushed, but nothing that moved the needle on indexes.
The Daily Dollar is auto-generated for informational and educational purposes only. Nothing here is financial advice, a recommendation to buy or sell, or a forecast. Markets are risky; do your own research.